Osaic Holdings
ATXI

Osaic Holdings’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Osaic Holdings’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed -$353 – 7497
2023
Q3 		$353 Buy
+7
New +$495 ﹤0.01% 7051
2020
Q3 		– Sell
-30
Closed -$363K – 6456
2020
Q2 		$363K Hold
30
– – ﹤0.01% 2616
2020
Q1 		$302K Buy
+30
New +$301K ﹤0.01% 2520

Other funds holding ATXI

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Osaic Holdings's ATXI Position: Q4 2023 in Review

Osaic Holdings sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q4 2023, closing a stake of 7 shares — an estimated $353 sold.

Osaic Holdings first reported a position in ATXI in Q1 2020 and held it in 3 quarters. The position peaked at $363K in Q2 2020. 14 funds tracked by Wall St. Rank hold ATXI as of Q4 2023.

  • Osaic Holdings reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Osaic Holdings sold 7 Avenue Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $353.
  • Osaic Holdings first reported a position in Avenue Therapeutics, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Osaic Holdings's Avenue Therapeutics, Inc. Common Stock position peaked at $363K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.